Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Pricing
Rankings
For Publishers
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Pricing
Rankings
For Publishers
Log In
Start Free Trial
Wenzhong Su
Sign up to set email alerts
28
Publications
5
Citation Statements Received
397
Citation Statements Given
How they've been cited
20
0
5
0
How they cite others
571
32
365
0
Affiliations
Shanxi Provincial Cancer Hospital
,
Shanxi Medical University
Publications
Order By: Most citations
Efficacy and Safety of Apatinib plus Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cancer: A Phase II Trial
Yang
1
,
Guo
2
,
Le
3
et al.
2022
BioMed Research International
Abstract
Show
5
0
2
0
Get article
Add to collection
Cite
Effectiveness of neoadjuvant immunochemotherapy compared to neoadjuvant chemotherapy in non-small cell lung cancer patients: Real-world data of a retrospective, dual-center study
Fei
1
,
Guo
2
,
Wang
3
et al.
2023
Front. Oncol.
Abstract
Show
4
0
1
0
Get article
Add to collection
Cite
Plain language summary: comparing ivonescimab with pembrolizumab in people with PD-L1–positive non-small cell lung cancer in the HARMONi–2 study
Wang
1
,
Yao
2
,
Shen
3
et al.
2025
Future Oncology
1
0
1
0
Get article
Add to collection
Cite
Pre-treatment peripheral blood TCR repertoire as a predictor of response in patients with NSCLC treated with immunochemotherapy
Yang
1
,
Jiang
,
Li
3
et al.
2025
BMC Cancer
5
0
1
0
Get article
Add to collection
Cite
Effect of defective H2B ubiquitination on the malignancy and repair of DNA double breaks and its significance in lung adenocarcinoma
An
1
,
Yao
2
,
Su
3
et al.
2025
Sci Rep
2
0
0
0
Get article
Add to collection
Cite
Effect of defective H2B ubiquitination on the malignancy and repair of DNA double breaks and its significance in lung adenocarcinoma
An
1
,
Yao
2
,
Su
3
et al.
2025
Preprint
Abstract
Show
0
0
0
0
Get article
Add to collection
Cite
Anlotinib combined with nab-paclitaxel and cisplatin as neoadjuvant treatment (NAT) for esophageal squamous cell carcinoma (ESCC): Update results of a single-arm, phase II clinical trial.
Zhang
1
,
Li
2
,
Hong
3
et al.
2023
JCO
Abstract
Show
0
0
0
0
Get article
Add to collection
Cite
Effectiveness and safety of serplulimab plus platinum-based chemotherapy in first-line treatment of extensive-stage small cell lung cancer liver metastases: a retrospective cohort study
Chen
1
,
Su
2
2025
Front. Oncol.
Abstract
Show
0
0
0
0
Get article
Add to collection
Cite
1
2